selected publications
- High variance in quantification of Mycobacterium tuberculosis at low bacterial loads and with differentially detectable mycobacteria. Antimicrobial agents and chemotherapy. 2024 Academic Article GET IT
- Clinically encountered growth phenotypes of tuberculosis-causing bacilli and their in vitro study: A review. Frontiers in cellular and infection microbiology. 2022 Review GET IT
- Transcriptional Biomarkers of Differentially Detectable Mycobacterium tuberculosis in Patient Sputum. mBio. 2022 Academic Article GET IT
-
Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected.
Science translational medicine.
2021
Academic Article
GET IT
Times cited: 17 - Characterization of Differentially Detectable Mycobacterium tuberculosis in the Sputum of Subjects with Drug-Sensitive or Drug-Resistant Tuberculosis before and after Two Months of Therapy. Antimicrobial agents and chemotherapy. 2021 Academic Article GET IT
-
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.
Life science alliance.
2020
Academic Article
GET IT
Times cited: 54 - Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression. 2020 GET IT
-
Early Bactericidal Activity Trial of Nitazoxanide for Pulmonary Tuberculosis.
Antimicrobial agents and chemotherapy.
2020
Academic Article
GET IT
Times cited: 24 -
Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis.
ACS infectious diseases.
2019
Academic Article
GET IT
Times cited: 12 - Synthesis and Antibacterial Evaluation of Cephalosporin Isosteres. Asian Journal of Organic Chemistry. 2019 Article GET IT
-
Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
mBio.
2018
Academic Article
GET IT
Times cited: 28 -
Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.
Nature communications.
2018
Academic Article
GET IT
Times cited: 58 -
Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations.
Proceedings of the National Academy of Sciences of the United States of America.
2017
Academic Article
GET IT
Times cited: 61 -
Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2016
Academic Article
GET IT
Times cited: 22 - Retrospective analysis of the prevalence of and factors associated with condom use among young HIV-infected women in Cameroon. SAGE open medicine. 2016 Academic Article GET IT
-
Factors associated with inconsistent condom use in adolescents with negative or unknown HIV status in Northwest Cameroon.
AIDS care.
2014
Academic Article
GET IT
Times cited: 15 -
Kinetic evidence for dihapto (eta(2)) pi-aryl participation in acid-catalyzed ring opening of diarylhomobenzoquinone epoxides.
The Journal of organic chemistry.
2010
Academic Article
GET IT
Times cited: 5 -
Post-embryonic expression of C. elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system.
Developmental dynamics : an official publication of the American Association of Anatomists.
2005
Academic Article
GET IT
Times cited: 80